Translational Development Acquisition Corp. (TDAC) Executive Compensation
Translational Development Acquisition Corp. (TDAC) is a publicly traded company on the Nasdaq, categorized under SIC 6770 (Blank Checks). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TDAC
CIK: 1926599
Exchange: Nasdaq
SIC 6770: Blank Checks
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
WithumSmith+Brown, PC
Auditor SinceSince 5/26/2022 12:00:00 AM
Lead Engagement PartnerPatrick Clancy
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 425 | 2026-10-08 | — | 425 | 0001193125-26-417910 | View SEC Doc Filr Page |
| 425 | 2026-09-24 | — | 425 | 0001193125-26-401002 | View SEC Doc Filr Page |
| 425 | 2026-09-14 | — | 425 | 0001193125-26-389768 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001104659-26-097093 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001905106-26-000146 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-351225 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-12 | — | SCHEDULE 13G/A Filing | 0000886982-26-000457 | View SEC Doc Filr Page |
| 425 | 2026-08-03 | — | 425 | 0001193125-26-330513 | View SEC Doc Filr Page |
| 425 | 2026-07-28 | — | 425 | 0001193125-26-320984 | View SEC Doc Filr Page |
| 425 | 2026-07-27 | — | 425 | 0001104659-26-087089 | View SEC Doc Filr Page |
| 8-K | 2026-07-27 | 2026-07-27 | FORM 8-K | 0001104659-26-087086 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-16 | — | SCHEDULE 13G/A Filing | 0001140361-26-028660 | View SEC Doc Filr Page |
| 8-K | 2026-07-08 | 2026-07-06 | FORM 8-K | 0001104659-26-081579 | View SEC Doc Filr Page |
| 425 | 2026-06-29 | — | 425 | 0001193125-26-286758 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-23 | — | DEFA14A | 0001104659-26-076687 | View SEC Doc Filr Page |
| 425 | 2026-06-23 | — | 425 | 0001104659-26-076686 | View SEC Doc Filr Page |
| 8-K | 2026-06-23 | 2026-06-22 | FORM 8-K | 0001104659-26-076684 | View SEC Doc Filr Page |
| 425 | 2026-06-23 | — | 425 | 0001193125-26-278623 | View SEC Doc Filr Page |
| 425 | 2026-06-22 | — | 425 | 0001193125-26-276612 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-17 | FORM 8-K | 0001104659-26-075471 | View SEC Doc Filr Page |
| 425 | 2026-06-15 | — | 425 | 0001193125-26-270239 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-12 | FORM 8-K | 0001104659-26-073428 | View SEC Doc Filr Page |
| 425 | 2026-06-10 | — | 425 | 0001193125-26-265584 | View SEC Doc Filr Page |
| 425 | 2026-06-02 | — | 425 | 0001193125-26-252878 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-06-02 | — | SCHEDULE 13G Filing | 0001193125-26-253165 | View SEC Doc Filr Page |